Articles from: ENZN (Enzon Pharmaceuticals Inc) (MSN Money)
 |
|
|
|
|
| Next Page
| |
|
| Enzon Announces Discontinuation of PEG-SN38 Program in Metastatic Colorecta (more) | 2011 05 19 |
|
|
|
| Top Biotech Picks by Hedge Fund and Mutual Fund Gurus Concentrated in the S (more) | 2011 05 09 |
|
|
| How Seth Klarman's Latest Transactions at Baupost Group Have Worked Out So (more) | 2011 04 27 |
|
|
|
|
|
| Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman of the Board; Adopts M (more) | 2011 03 17 |
|
|
|
|
| 20 Oversold Stocks That Are Undervalued Relative to the Graham Number (more) | 2011 02 24 |
|
|
|
|
|
|
|
| Enzon to Release Fourth Quarter 2010 Earnings on Thursday, February 17, 201 (more) | 2011 02 10 |
|
|
|
|
|
|
|
|
| Enzon to Begin Phase 1 Study of Novel Androgen Receptor mRNA Antagonist in (more) | 2011 01 10 |
|
|
|
|
|
|
|
|
| Enzon Announces the Initiation of Two Phase I Studies in Collaboration wit (more) | 2010 12 15 |
|
|
|
|
|
| Enzon Pharmaceuticals Awarded $1.2 Million in Grants under QTDP Program (more) | 2010 11 02 |
|
|
| CORRECTING and REPLACING Abstracts Highlighting Data from Enzon's mRNA Anta (more) | 2010 11 01 |
|
|
| Enzon to Release Third Quarter 2010 Earnings on Tuesday, November 2, 2010 (more) | 2010 10 26 |
|
| Enzon Announces Publication of Preclinical Study Data of PEG-SN38 in Pediat (more) | 2010 10 05 |
|
|
| Next Page
| |